Indeed, the inflammatory-mediated activation of PTP1B has been shown to disrupt metabolic-related signalling pathways in Alzheimer’s disease, leading to disease progression [69]. Here, PTPN1 is linked to early-onset autosomal dominant Alzheimer disease.